Sequent Scientific Q1 Results
- BSE: 512529
- NSE: SEQUENT
- ISIN: INE807F01027
- Sector: Biotechnology & Drugs
BSE
171
-6.85 (-3.85%)
-6.85 (-3.85%)Volume57.49 K
Updated: Fri 24 Jan, 2025 | 15:29:38
NSE
171.95-4.87 (-2.75%)
-4.87 (-2.75%)Volume2.56 L
Updated: Fri 24 Jan, 2025 | 15:29:58
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Sequent Scientific Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 24 | Mar 24 | QoQ Comp | Jun 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 390.21 | 361.20 | 8.03% | 333.21 | 17.11% |
| Selling/ General/ Admin Expenses Total | 62.05 | 62.19 | -0.23% | 64.16 | -3.30% |
| Depreciation/ Amortization | 16.25 | 16.48 | -1.42% | 14.24 | 14.11% |
| Other Operating Expenses Total | 71.14 | 70.21 | 1.32% | 79.74 | -10.79% |
| Total Operating Expense | 363.73 | 348.13 | 4.48% | 376.47 | -3.38% |
| Operating Income | 26.48 | 13.07 | 102.66% | -43.26 | 0.00% |
| Net Income Before Taxes | 12.00 | 2.64 | 355.24% | -55.68 | 0.00% |
| Net Income | 6.51 | -0.91 | 0.00% | -34.85 | 0.00% |
| Diluted Normalized EPS | 0.26 | 0.05 | 377.94% | -0.79 | 0.00% |